Leadership Overview
Pacira has 4 executives leading key functions including finance, medical affairs, legal, and administration.
Driven by a desire to improve the world, Pacira advances non-opioid pain management and regenerative health solutions, making a meaningful difference in patient outcomes and communities.
Driven by a desire to improve the world, Pacira advances non-opioid pain management and regenerative health solutions, making a meaningful difference in patient outcomes and communities.
Leadership Roles at Pacira
Charles Reinhart - Chief Financial Officer
Charles Reinhart, the Chief Financial Officer at Pacira, directs all financial operations and strategic fiscal planning. Overseeing budgeting, forecasting, and financial reporting, the Chief Financial Officer ensures robust fiscal health and supports the company's growth initiatives in non-opioid pain management. This leadership role involves managing capital allocation, investor relations, and risk management to align with Pacira's mission of advancing patient outcomes. By optimizing financial strategies, Charles Reinhart directly contributes to the company's ability to develop and deliver innovative regenerative health solutions. Ultimately, Reinhart secures long-term financial stability and supports the expansion of Pacira's market presence.
Jonathan Slonin - Chief Medical Officer
Jonathan Slonin, the Chief Medical Officer at Pacira, guides the company's medical strategy and clinical development. Overseeing all medical affairs, the Chief Medical Officer ensures that Pacira's non-opioid pain management and regenerative health solutions meet the highest standards of patient care and efficacy. This critical role involves translating scientific research into actionable clinical strategies and fostering collaborations with healthcare professionals to advance patient outcomes. By championing evidence-based medicine, Jonathan Slonin directly supports the development of innovative treatments that improve lives. Ultimately, Slonin drives the medical vision, ensuring Pacira remains at the forefront of patient-centric healthcare innovation.

Anthony Molloy - Chief Legal Officer & Chief Compliance Officer
Anthony Molloy, the Chief Legal Officer & Chief Compliance Officer at Pacira, provides strategic legal counsel and ensures adherence to all regulatory requirements. Overseeing the legal department and compliance functions, the Chief Legal Officer & Chief Compliance Officer safeguards the company's operations and upholds its commitment to ethical practices in the pharmaceutical sector. This leadership position involves managing corporate governance, intellectual property, and risk mitigation strategies critical to Pacira's mission. By ensuring strict compliance, Anthony Molloy directly supports the company's ability to deliver safe and effective non-opioid pain management solutions. Ultimately, Molloy fortifies Pacira's integrity and operational resilience.

Kristen Williams - Chief Administrative Officer & Secretary
Kristen Williams, the Chief Administrative Officer & Secretary at Pacira, directs essential administrative functions and corporate governance. Overseeing human resources, facilities, and corporate communications, the Chief Administrative Officer & Secretary ensures efficient operations and supports the company's strategic objectives. This role is vital for maintaining a productive work environment and facilitating seamless communication across all departments, aligning with Pacira's dedication to improving patient outcomes. By managing key operational infrastructure, Kristen Williams directly enhances the company's capacity to innovate in regenerative health solutions. Ultimately, Williams provides the foundational support necessary for Pacira's continued success and mission fulfillment.

Explore Leadership Teams in Manufacturing
Teva Pharmaceutical Industries Ltd. is a global biopharmaceutical leader focused on improving health outcomes for patients worldwide. Enabled by a world-class generics business, Teva develops, manufactures, and delivers a broad portfolio of medicines, including complex generics, biosimilars, innovative therapies, and pharmacy brands. The company is dedicated to addressing unmet patient needs by advancing scientific research, expanding access to quality medicines, and streamlining the delivery of treatments -from established generics to cutting-edge therapeutic solutions.
Company Leadership HL
CO
AJ

Sarepta Therapeutics, Inc. is a global commercial-stage biopharmaceutical company founded in 1980 and headquartered in Cambridge, Massachusetts. The company is focused on the discovery, development, and commercialization of precision genetic medicines for rare diseases, with particular leadership in Duchenne muscular dystrophy and limb-girdle muscular dystrophies. Sarepta's multi-platform Precision Genetic Medicine Engine spans gene therapy, RNA-targeted therapeutics, and gene editing modalities. The company holds multiple FDA-approved treatments and maintains a broad pipeline of programs across neuromuscular and central nervous system disorders. Sarepta operates globally with locations across North America, Europe, and Asia, and trades on the NASDAQ under the ticker symbol SRPT.
Company Leadership FQ
IE
WT
KM
USV Private Limited is an Indian multinational pharmaceutical and biotechnology company headquartered in Mumbai, India. USV Limited was established in 1961.
Company Leadership SY
AM
Founded in 1850 and headquartered in Johannesburg, South Africa, Aspen Pharmacare Holdings Limited is a global specialty and branded pharmaceutical company headquartered in Durban, South Africa. Operating across Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia, Aspen focuses on sterile injectables (including anaesthetics, anticoagulants, antithrombotics, analgesics, and hormone replacement therapies), over-the-counter medicines, and prescription products for conditions such as hypothyroidism, autoimmune disease, pain, gout, and inflammatory disorders. The company also manufactures active pharmaceutical ingredients and finished dose forms, including steriles, oral solids, liquids, semi-solids, biologicals, and heparins, supplying both its own brands and third-party customers worldwide.
Company Leadership

TS
JW